NCT03251729View on ClinicalTrials.gov

Cerclage On LOw Risk Singletons: Cervical Cerclage for Prevention of Spontaneous Preterm Birth in Low Risk Singleton Pregnancies With Short Cervix

PHASE4CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

September 22, 2017

Primary Completion Date

February 20, 2024

Study Completion Date

February 20, 2024

Conditions
Premature Birth
Interventions
PROCEDURE

Cervical cerclage

Transvaginal cervical cerclage placed between 18 0/7 - 23 6/7 weeks

DRUG

Vaginal progesterone

Vaginal progesterone 200mg suppository or 90mg gel nightly from randomization until 36 weeks

Trial Locations (3)

19107

Thomas Jefferson University Hospital, Philadelphia

Unknown

University of Naples Federico II, Naples

University Cattolica del S. Cuore, Rome

All Listed Sponsors
lead

Thomas Jefferson University

OTHER

NCT03251729 - Cerclage On LOw Risk Singletons: Cervical Cerclage for Prevention of Spontaneous Preterm Birth in Low Risk Singleton Pregnancies With Short Cervix | Biotech Hunter | Biotech Hunter